{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "Patient diagnosed with limited-stage SCLC at Peking University Cancer Hospital on August 1, 2020.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C8014684",
              "label": "Small cell lung cancer",
              "status": "active",
              "onset_date": "2020-08-01"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient administered four cycles of carboplatin plus etoposide combined with duvalizumab.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007129",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0015087",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "duvalizumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "After chemotherapy, the patient's primary tumor was partially reduced in size.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Chemotherapy",
              "outcome": "Partial response"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Patient received a total of 30 radiotherapy sessions to the primary lung cancer lesion in the right hilar region.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Radiotherapy",
              "approach": "other",
              "date": null,
              "location": "right hilar region",
              "performed_by": null,
              "outcome": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "lung cancer",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient diagnosed with extensive stage-small cell lung cancer (ES-SCLC) and brain metastases after initial treatment.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C8014",
              "label": "Small cell carcinoma of lung, extensive stage",
              "status": "active"
            },
            {
              "code": "C79.31",
              "label": "Secondary malignant neoplasm of brain",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient received bevacizumab in combination with irinotecan as a post-fourth-line therapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1307282",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0022042",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient achieved a significant partial response to bevacizumab and irinotecan. Tumor was significantly reduced in size after chemotherapy and radiotherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0005837",
              "indication": "Neoplasm"
            },
            {
              "drug": "C0698894",
              "indication": "Neoplasm"
            }
          ],
          "procedures": [
            {
              "name": "C0008590",
              "outcome": "Partial Response"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient received preventive cranial irradiation to prevent brain metastasis.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Preventive cranial irradiation",
              "approach": "other",
              "location": "cranium",
              "outcome": "prevention of brain metastasis"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Patient received 12 cycles of immune maintenance therapy until lesion recurrence in December 2021.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0265150",
              "label": "Recurrence",
              "status": "active",
              "onset_date": "2021-12"
            }
          ],
          "procedures": [
            {
              "name": "C4721489",
              "date": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Patient received original chemotherapy regimen again for four cycles at Peking University Cancer Hospital from early December 2021 to February 2022.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Chemotherapy",
              "date": "2021-12-01",
              "location": "Peking University Cancer Hospital"
            },
            {
              "name": "Chemotherapy",
              "date": "2022-02-28",
              "location": "Peking University Cancer Hospital"
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Patient received eight rounds of stereotactic radiation therapy for recurrent lesions in March 2022, achieving complete remission.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Stereotactic Radiation Therapy",
              "date": "2022-03",
              "outcome": "complete remission"
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "Patient found to have brain metastases, treated with stereotactic radiation therapy.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0242963",
              "label": "Brain metastasis",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "C1704453",
              "approach": "other",
              "date": null,
              "location": "Brain",
              "performed_by": null,
              "outcome": null
            }
          ],
          "imaging": [
            {
              "type": "C0006115",
              "body_part": "C0005729",
              "modality": null,
              "finding": "Brain metastases",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "New metastatic lesion found in the right lung in July 2022. Patient received treatment with anlotinib.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Metastatic lesion",
              "body_part": "Right lung",
              "modality": "unknown",
              "finding": "Metastatic lesion",
              "impression": "New metastatic lesion found",
              "date": "2022-07"
            }
          ],
          "medications": [
            {
              "drug": "anlotinib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "Metastatic lesion"
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "Brain MRI at the end of October 2022 showed the brain tumor had shrunk to 4 mm \u00d7 2 mm.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Brain MRI",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "tumor shrunk to 4 mm \u00d7 2 mm",
              "date": "2022-10"
            }
          ]
        }
      }
    },
    {
      "id": "N15",
      "label": "Step 15",
      "customData": {
        "node_id": "O",
        "node_step_index": 14,
        "content": "Brain MRI on January 18, 2023, revealed the tumor was 10 times larger. Anlotinib was discontinued.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Brain MRI",
              "body_part": "Brain",
              "modality": "MRI",
              "date": "2023-01-18",
              "finding": "tumor was 10 times larger"
            }
          ],
          "medications": [
            {
              "drug": "Anlotinib",
              "end_date": "2023-01-18"
            }
          ]
        }
      }
    },
    {
      "id": "N16",
      "label": "Step 16",
      "customData": {
        "node_id": "P",
        "node_step_index": 15,
        "content": "Patient underwent two cycles of chemotherapy with paclitaxel-albumin.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030371",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0009372",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N17",
      "label": "Step 17",
      "customData": {
        "node_id": "Q",
        "node_step_index": 16,
        "content": "Pro-GRP level: 1161 pg/mL on 2023-01-01.",
        "clinical_data": {
          "labs": [
            {
              "test": "Pro-gastrin-releasing peptide",
              "value": "1161",
              "unit": "pg/mL",
              "timestamp": "2023-01-01"
            }
          ]
        }
      }
    },
    {
      "id": "N18",
      "label": "Step 18",
      "customData": {
        "node_id": "R",
        "node_step_index": 17,
        "content": "",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Initiation of treatment following diagnosis.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0007129",
            "C0015087",
            "duvalizumab"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Response to initial chemotherapy regimen.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "Chemotherapy"
          ],
          "change_type": "other",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Administration of radiotherapy to the primary lung cancer lesion.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "Radiotherapy"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Disease progression to extensive stage SCLC with brain metastases.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C8014",
            "C79.31"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of bevacizumab and irinotecan as post-fourth-line therapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1307282",
            "C0022042"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Significant partial response to bevacizumab and irinotecan.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0008590"
          ],
          "change_type": "other",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Preventive cranial irradiation to prevent brain metastasis.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "Preventive cranial irradiation"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Immune maintenance therapy followed by lesion recurrence.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0265150"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis",
          "timestamp": "2021-12-01T00:00:00Z"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Re-administration of original chemotherapy regimen.",
        "transition_event": {}
      }
    }
  ]
}